Category Archives: Pharmaceutical Litigation

Product liability lawyers on pharmaceutical litigation involving dangerous and recalled medication and medical devices.

Why Is the FDA Recalling Valsartan Products from Drug Stores?

Do you take medication to treat high blood pressure or heart failure? If so, then you need to know about the latest recall from the FDA. Some pharmaceuticals containing the active ingredient valsartan are being recalled due to impurities found by the FDA. That means if you are taking a medicine containing this ingredient, you need to call your doctor’s…
Read More »

Posted in Pharmaceutical Litigation | Tagged , | Leave a comment

Is EpiPen Price Gouging Going to Lead to Lawsuits?

There is much outrage over the increase in EpiPen pricing from the internet as well as from the patients that need the life-saving medication. The EpiPen device is used to stop life-threatening allergic reactions to common allergens such as bee stings, peanuts or other types of foods. The auto-injector device is stored in a convenient, small container and is injected…
Read More »

Posted in Pharmaceutical Litigation | Tagged | Leave a comment

Things You Didn’t Know About Dietary Supplements

In 2013 a transplant surgeon noticed the high number of people coming to her hospital with liver failure. She interviewed several of these patients and found that they had all taken the OxyElite Pro fitness supplement. The discovery led to a nationwide recall, and several lawsuits were filed, but it also exposed a danger that many Americans never suspected. Things…
Read More »

Posted in Pharmaceutical Litigation | Tagged | Leave a comment

Act Now For Xarelto Suits: Time Running Out

We have been keeping you up-to-date on the progress of the Xarelto multidistrict litigations, so we wanted to let you know that time is running out for any victims who have suffered injuries or lost loved ones due to this potentially harmful drug. Act Now For Xarelto Suits On September 17th, Judge Eldon Fallon signed a court order to begin…
Read More »

Posted in Pharmaceutical Litigation | Tagged | 2 Comments

Daiichi Sankyo Still Paying Fines for Benicar Doctor Kickbacks

Pharmaceutical giant Daiichi Sankyo has been ordered to pay another fine, the time in New Jersey, totaling $690,000. This comes after reaching a settlement in January to pay the U.S. federal government and Medicaid programs $39 million. This latest fine was an expansion of the previous settlement where a whistleblower accused the company of soliciting doctors to file false insurance…
Read More »

Posted in Pharmaceutical Litigation | Tagged | Leave a comment

Xarelto Cases Fast Approaching Court Date

More news on our continued coverage of the Xarelto mass tort cases: June 11th is fast approaching, a significant day for members of the Xarelto federal multidistrict litigation. That day is when the attorneys for the plaintiffs get to present their scientific evidence to the court, and drive home their claims that they have linked bleeding complications to improperly disclosed…
Read More »

Posted in Pharmaceutical Litigation | Tagged | Leave a comment